In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
TB500 is thought to work throughout your whole body, not just in one spot
This is important for the incretin effect which works with GLP-1 to reduce blood sugar and assist with losing weight
KO, n = 7 representative from 2 independent experiments, p = 0.7441) (b) , tGSH levels (p = 0.001, WT, n = 4
Doctors emphasize not increasing the dose too quickly
And if makeup is part of your daily routine, opt for a cleanser that supports double cleansing or easily removes residue